4 comments By Andrea Peirce, BA, Writer/Editor | Friday, October 31, 2014 The team of experts in our RISE Program tailor each woman’s surveillance plan based on the latest findings in breast cancer risk, prevention, and treatment. read more
Add a Comment By Esther Napolitano, BS, Science Writer/Editor | Monday, October 20, 2014 Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials.
1 comment By Esther Napolitano, BS, Science Writer/Editor | Wednesday, September 24, 2014 Medical oncologist Paul Sabbatini sheds light on how phase I clinical trials are conducted at Memorial Sloan Kettering and how to determine whether patients may be eligible for one. read more
6 comments By Esther Napolitano, BS, Science Writer/Editor | Thursday, April 17, 2014 Molecular analysis of lung tumors can help guide treatment decisions. Memorial Sloan Kettering is one of only a handful of centers nationwide to offer this personalized approach to care. read more
Add a Comment By Media Staff | Tuesday, July 9, 2013 Medical oncologist Mark G. Kris and one of his patients were interviewed for a CBS This Morning segment that describes how a Memorial Sloan-Kettering team trains the supercomputer IBM Watson to help doctors identify the best cancer management options for individual patients. read more